Key takeaways
- Audit letdown ratios against measured ΔE, not legacy specifications
- Masterbatch reformulations can silently invalidate old dosing assumptions
- Under-dosing is a quality risk as real as over-dosing is a cost
- Put color specifications on a fixed revalidation cycle